Hereditary transthyretin amyloidosis - patisiran or vutrisiran - continuing authority application form (PB368)

Use this form to apply to continue PBS-subsidised treatment with patisiran or vutrisiran for adult patients with hereditary transthyretin amyloidosis.

Page last updated: 1 May 2025.
QC 74416